Novalgine (Metamizole Sodium)

Metamizole sodium, the active ingredient in Novalgine, is a non‑opioid analgesic presented as an oral formulation for systemic use. It is employed to relieve moderate to severe pain and to reduce high fever in adult patients, providing an alternative when opioid therapy is not required.

GNH USA supplies Novalgine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers.

Novalgine (metamizole sodium) is used in the management of acute pain and fever, acting within the prostaglandin pathway.

- Pain: provides rapid analgesic relief for moderate to severe acute pain. - Fever: lowers elevated body temperature in febrile conditions. - Post‑operative pain: helps control pain after surgical procedures. - Colicky abdominal pain: alleviates spasmodic pain associated with gastrointestinal cramps.

Metamizole sodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Dizziness: transient light‑headedness. - Rash: mild skin irritation. - Hypotension: temporary low blood pressure.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cell count. - Anaphylaxis: acute, potentially life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Hepatotoxicity: liver injury or enzyme elevation.

When using Novalgine, several safety considerations should be observed to minimize risk.

- Blood count monitoring: perform regular complete blood counts to detect early signs of agranulocytosis. - Hypersensitivity avoidance: discontinue if any allergic reaction such as rash or swelling occurs. - Renal impairment caution: adjust use in patients with reduced kidney function. - Hepatic impairment caution: use carefully in patients with liver disease. - Concomitant NSAID use: avoid combining with other non‑steroidal anti‑inflammatory drugs to reduce toxicity. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Metamizole sodium can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk when used together. - Other myelosuppressive agents: combined use can potentiate bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect may require dose adjustment. - Diuretics: concurrent use may affect renal clearance. - Lithium: metamizole may raise lithium serum levels, necessitating monitoring.